The conundrum of the gram-positive rod: Are we missing important pathogens in complicated skin and soft-tissue infections? A case report and review of the literature

Surgical Infections

Volumn 11, Issue 1, 2010, Pages 65-72

  Clarke, Tatyan M ^a   Citron, Diane M ^b   Towfigh, Shirin ^c  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b R M ALDEN RESEARCH LABORATORY   (United States)

^c CEDARS SINAI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CEFTRIAXONE; CLINDAMYCIN; COTRIMOXAZOLE; ERYTHROMYCIN; LEVOFLOXACIN; PENICILLIN G; PIPERACILLIN PLUS TAZOBACTAM; RNA 16S; TETRACYCLINE; VANCOMYCIN;

ADULT; ARCANOBACTERIUM; ARCANOBACTERIUM BERNARDIAE; ARTICLE; BACTERIAL VIRULENCE; BACTERIUM CULTURE; BACTERIUM IDENTIFICATION; CASE REPORT; CLINICAL FEATURE; FEMALE; HUMAN; NECROTIZING FASCIITIS; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RNA SEQUENCE; SKIN INFECTION; SOFT TISSUE INFECTION; SPECIES IDENTIFICATION;

ARCANOBACTERIUM; DEBRIDEMENT; DNA, BACTERIAL; DNA, RIBOSOMAL; FASCIITIS, NECROTIZING; FEMALE; GRAM-POSITIVE BACTERIAL INFECTIONS; GRAM-POSITIVE RODS; HUMANS; MIDDLE AGED; RNA, RIBOSOMAL, 16S; SEQUENCE ANALYSIS, DNA; SKIN DISEASES, BACTERIAL; SOFT TISSUE INFECTIONS;

EID: 77349106918     PISSN: 10962964     EISSN: None     Source Type: Journal    
DOI: 10.1089/sur.2008.085     Document Type: Article

References (47)

1. U.S. Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER), Guidance for Industry: Uncomplicated and Complicated Skin and Skin Structure Infections - Developing Antimicrobial Drugs for Treatment [on-line]. Available at http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/ Guidances/UCM071185.pdf accessed August 4, 2009.
2. Anaya DA, Dellinger EP. Necrotizing soft-tissue infection: diagnosis and management. Clin Infect Dis 2007;44:705-10.
3. Gunter OL, Guillamondegui OD, May AK, Diaz JJ. Outcome of necrotizing skin and soft tissue infections. Surg Infect (Larchmt) 2008;9:443-50.
4. Lee SY, Kuti JL, Nicolau DP. Antimicrobial management of complicated skin and skin structure infections in the era of emerging resistance. Surg Infect 2005;6:283-295.
5. Wilson SE. Clinical trial results with linezolid, an oxazolidinone, in the treatment of soft tissue and postoperative gram-positive infections. Surg Infect (Larchmt) 2001;2:25-35.
6. Green RJ, Dafoe DC, Raffin TA. Necrotizing fasciitis. Chest 1996;110:219.
7. Hefny AF, Eid HO, Al-Hussona M, et al. Necrotizing fasciitis: a challenging diagnosis. Eur J Emerg Med 2007;14:50-52.
8. Salcido R, Ahn C. Necrotizing fasciitis: reviewing the causes and treatment strategies. Adv Skin Wound Care 2007;20: 288-293.
9. Smith GH, Huntley JS, Keenan GF. Necrotising myositis: a surgical emergency that may have minimal changes in the skin. Emerg Med J 2007;24:e8.
10. Umbert IJ, Winkelmann RK, Oliver GF. Necrotizing fasciitis: a clinical, microbiologic, and histopathologic study of 14 patients. J Am Acad Dermatol 1989;20:774-781.
11. Chelsom J, Halstensen A, Haga T. Necrotizing fasciitis due to group A streptococci in western Norway: incidence and clinical features. Lancet 1994;344:1111-1115.
12. Yamane K, Asato J, Kawade N, et al. Two cases of fatal necrotizing fasciitis caused by Photobacterium damsela in Japan. J Clin Microbio 2004;42:1370-1372.
13. Byrnes JM. Necrotizing fasciitis: a common problem in Darwin. Int J Low Extrem Wounds 2006;5:271-276.
14. Bygott AM, et al. First clinical case of Corynebacterium auriscanis isolated from localized dog bite infection. J Med Microbiol 2008;57(Pt 7):899-900.
15. Holmes NE, et al. Corynebacterium kutscheri infection of skin and soft tissue following rat bite. J Clin Microbiol 2007;45:3468-3469.
16. Goldstein EJ, Citron DM, Merriam CV, Warren YA, Tyrrell KL, Fernandez HT. Comparative in vitro activity of faropenem and 11 other antimicrobial agents against 405 aerobic and anaerobic pathogens isolated from skin and soft tissue infections from animal and human bites. J Antimicrob Chemother 2002;50:411-420.
17. Andriessen MJ, Kotsopoulos AM, Bloemers FW, et al. Necrotizing fasciitis caused by Salmonella enteritidis. Scand J Infect Dis 2006;38:1106-1107.
18. Li DM, Lun LD, Chen XR. Necrotizing fasciitis with Escherichia coli. Lancet Infect Dis 2006;6:456.
19. McHenry CR, Brandt CP, Piotrowski JJ, et al. Idiopathic necrotizing fasciitis: recognition, incidence and outcome of therapy. Am Surg 1994;60:490-494.
20. Anaya DA, Dellinger EP. Necrotizing soft-tissue infection: diagnosis and management. Clin Infect Dis 2007; 44:705-710.
21. Golger A, Ching S, Goldsmith CH, et al. Mortality in patients with necrotizing fasciitis. Plast Reconstr Surg 2007; 119:1803-1807.
22. Ozalay M, Ozkoc G, Akpinar S, et al. Necrotizing soft-tissue infection of a limb: clinical presentation and factors related to mortality. Foot Ankle Int 2006;27:598-605.
23. Morgan WR, Caldwell MD, Brady JM, et al. Necrotizing fasciitis due to a methicillin-sensitive Staphylococcus aureus isolate harboring an enterotoxin gene cluster. J Clin Microbiol 2007;45:668-671.
24. Rogers RL, Perkins J. Skin and soft tissue infections. Prim Care 2006;33:697-710.
25. Rotstein OD. Interactions between leukocytes and anaerobic bacteria in polymicrobial surgical infections. Clin Infect Dis 1993;16 Suppl 4:S190-S194.
26. Lee S, Roh KH, Kim CK, et al. A case of necrotizing fasciitis due to Streptococcus agalactiae, Arcanobacterium haemolyticum, and Finegoldia magna in a dog-bitten patient with diabetes. Korean J Lab Med 2008;28:191-195.
27. Citron DM, Goldstein EJC, Merriam CV, et al. Bacteriology of moderate to severe diabetic foot infections and in vitro activity of antimicrobial agents. J Clin Microbiol 2007;45:2819-2828.
28. Na'was TE, Hollis DG, Moss CW, Weaver RE. Comparison of biochemical characteristics of Centers for Disease Control fermentative coryneform groups 1, 2, and A-4. J Clin Microbiol 1987;25:1354-1358.
29. Funke G, Ramos CP, Fernandez-Garayzabal JF, et al. Description of human-derived Centers for Disease Control coryneform group 2 bacteria as Actinomyces bernardiae sp. nov. Int J Syst Bacteriol 1995;45:57-60.
30. Bollinger, O. Ueber eine neue Pilzkrankheit beim Rinde. Zentralblatt, Medizinische Wissenschaft 1877;15:481-490.
31. Breed RS, Conn HJ. The nomenclature of actinomycetaceae. J Bacteriol 1919;IV:6.
32. Harz CO. Actinomyces bovis, ein neuer Schimmel in den Geweben des Rindes. Deutsche Zeitschr fb Tiermed., Supple. to Bd. 5 ( Jahresber.d. k. Central-Tierarznei Schule in Munchen for 1877-78. 1879:125-140.
33. Israel J. Neue Beobachtungen auf dem Gebiete der Mykosen des Menschen. Arch Patholog Anat 1878;64:15-31.
34. Wolfe M, Israel J. Ueber Reincultur des Actinomyces und seine Uebertragbarkeit auf Thiere. Arch Patholog Anat 1891; 126:11-28.
35. Georg LK, Roberstad GW, Brinkman SA. Identification of species of actinomyces. J Bacteriol 1964;88:477-490.
36. Thompson L. Isolation and comparison of Actinomyces from human and bovine infections. Proc Staff Meetings Mayo Clinic 1950;25:81-90.
37. McGinley KJ, Labows JN, Zeckman JM, Nordstrom et al. Pathogenic JK group corynebacteria and their similarity to human cutaneous lipophilic diphtheroids. J Infect Dis 1985;152:801-806.
38. Rubinfeld RS, Cohen EJ, Arentsen JJ, Laibson PR. Diphtheroids as ocular pathogens. Am J Ophthalmol 1989;108: 251-254.
39. Collins MD, Jones D, Schofield GM. Reclassification of 'Corynebacterium haemolyticum' (MacLean, Liebow & Rosenberg) in the genus Arcanobacterium gen.nov. as Arcanobacterium haemolyticum nom.rev., comb.nov. J Gen Microbiol 1982;128:1279-1281.
40. Ramos CP, Foster G, Collins MD. Phylogenetic analysis of the genus Actinomyces based on 16S rRNA gene sequences: description of Arcanobacterium phocae sp. nov., Arcanobacterium bernardiae comb. nov., and Arcanobacterium pyogenes comb. nov. Int J Syst Bacteriol 1997;47:46-53.
41. Santala AM, Sarkonen N, Hall V, et al. Evaluation of four commercial test systems for identification of actinomyces and some closely related species. J Clin Microbiol 2004;42: 418-420.
42. Clarridge JE, Zhang Q. Genotypic diversity of clinical actinomyces species: phenotype, source, and disease correlation among genospecies. J Clin Microbio 2002;40:3442-3448.
43. Sarkonen N, Kononen E, Summanen P, et al. Phenotypic identification of Actinomyces and related species isolated from human sources. J Clin Microbiol 2001;39:3955-3961.
44. Thomas M. Differentiation of streptococci from diphtheroids. Br Med J 1977;1:1159.
45. Lepaurgeneur JP, Heller R, Soulie R, Riegel P. Urinary tract infection due to Arcanobacterium bernardiae in a patient with a urinary tract diversion. Eur J Clin Microbiol Infect Dis 1998;17:399-401.
46. Adderson EE, Croft A, Leonard R, Carroll K. Septic arthritis due to Arcanobacterium bernardiae in an immunocompromised patient. Clin Infect Dis 1998;27:211-212.
47. Goldberg J, Weinstein M, Fagan M, et al. Gluteal necrotizing myofasciitis: an unusual delayed complication of abdominal sacrocolpoplexy. Am J Obstet Gynecol 2001;185:1273-1274.